Gabriela Gutierrez

Gabriela Gutiérrez is a pivotal figure in the field of medical sciences, serving as the Founder of Microgenesis Corporation since December 2019, where innovative tests and services related to microbiota and miRNAs research are developed to enhance human health, notably through the creation of GYNOMA for improving women's fertility and health issues. Simultaneously, Gutiérrez has been the Founder of Inmunogenesis since July 2015, focusing on technology to identify fertility challenges through products like TiME and the collaboration with Pronacera Therapeutics to offer FERT&i, which evaluates the receptivity of the endometrium. Gutiérrez also holds a position as Científico investigador at CONICET since December 2005 and has prior experience in R&D at Halitus Instituto Médico S.A. from March 2008 to March 2014. Educational qualifications include a Doctorado in Ciencias biomédicas from the University of Buenos Aires and a Licenciatura in Ciencias biológicas y biomédicas from Universidad CAECE, complemented by independent researcher training in medical sciences and technology at CONICET.